Resveratrol Reduce the Severity of Anemia and Thrombocytopenia in Plasmodium berghei ANKA-Infected Mice
Authors:
Open Access
- 21 December 2023
- journal article
- research article
- Published by Universitas Airlangga in Jurnal Farmasi dan Ilmu Kefarmasian Indonesia
- Vol. 10 (3) , 266-271
Abstract
Background: Malaria is an infectious disease with a high mortality rate. One of the complications of malaria is blood disorders. Hematological disorders such as anemia and thrombocytopenia are common in malaria infection. Resveratrol has been reported to have antimalarial activity. Objective: This study aimed to evaluate the effect of resveratrol in reducing the severity of anemia and thrombocytopenia in Plasmodum berghei-infected mice. Methods: The study began with parasite inoculation in mice. After the mice were infected, and randomly grouped into negative control, chloroquine 20 mg/kg (positive control), and resveratrol with doses 25, 50, and 100 mg/kg. The mice's blood profile was measured on day 0 and day 4 using a hematology analyzer. Results: The results showed that after administration of resveratrol at various doses, the number of RBC, hemoglobin, hematocrit and platelets was higher than the control. Conclusion: It can be concluded that resveratrol can reduce the severity of anemia and thrombocytopenia in mice infected with P. berghei.Keywords
This publication has 17 references indexed in Scilit:
- Health benefits of resveratrol administrationActa Biochimica Polonica, 2019
- pfmdr1 (Plasmodium falciparum multidrug drug resistance gene 1): a pivotal factor in malaria resistance to artemisinin combination therapiesExpert Review of Anti-infective Therapy, 2017
- In vivoantimalarial efficacy of acetogenins, alkaloids and flavonoids enriched fractions fromAnnona crassifloraMart.Natural Product Research, 2014
- Malaria: a haematological diseaseHematology, 2012
- Extracellular Methemoglobin Mediated Early ROS Spike Triggers Osmotic Fragility and RBC Destruction: An Insight into the Enhanced Hemolysis During MalariaIndian Journal of Clinical Biochemistry, 2011
- Artemisinin Resistance inPlasmodium falciparumMalariaNew England Journal of Medicine, 2009
- Antimalarial activity in mice of resveratrol derivative fromPleuropterus ciliinervisPathogens and Global Health, 2008
- Platelet‐Induced Clumping ofPlasmodium falciparum–Infected Erythrocytes from Malawian Patients with Cerebral Malaria—Possible Modulation In Vivo by ThrombocytopeniaThe Journal of Infectious Diseases, 2008
- Blood and bone marrow changes in malariaBest Practice & Research Clinical Haematology, 2000
- Plasma Macrophage Colony-Stimulating Factor and P-Selectin Levels in Malaria-Associated ThrombocytopeniaThrombosis and Haemostasis, 1997